HomeCompareDUK vs BAX

DUK vs BAX: Dividend Comparison 2026

DUK yields 3.22% · BAX yields 2.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DUK wins by $3.3K in total portfolio value· pulled ahead in Year 4
10 years
DUK
Duke Energy Corporation
● Live price
3.22%
Share price
$131.74
Annual div
$4.24
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.9K
Annual income
$1,399.71
Full DUK calculator →
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →

Portfolio growth — DUK vs BAX

📍 DUK pulled ahead of the other in Year 4

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDUKBAX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DUK + BAX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DUK pays
BAX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DUK
Annual income on $10K today (after 15% tax)
$273.57/yr
After 10yr DRIP, annual income (after tax)
$1,189.75/yr
BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
At 15% tax rate, DUK beats the other by $1,181.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DUK + BAX for your $10,000?

DUK: 50%BAX: 50%
100% BAX50/50100% DUK
Portfolio after 10yr
$22.3K
Annual income
$704.98/yr
Blended yield
3.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BAX right now

DUK
Analyst Ratings
12
Buy
19
Hold
Consensus: Hold
Price Target
$133.40
+1.3% upside vs current
Range: $115.00 — $143.00
Altman Z
0.7
Piotroski
6/9
BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DUK buys
13
BAX buys
0
PoliticianChamberTickerTypeAmountDate
Marjorie Taylor Greene🏢 House$DUK▲ Buy$1,001 - $15,0002025-09-11
Lisa McClain🏢 House$DUK▲ Buy$1,001 - $15,0002025-06-17
Marjorie Taylor Greene🏢 House$DUK▲ Buy$1,001 - $15,0002025-05-05
Tommy Tuberville🏛 Senate$DUK▼ Sell$15,001 - $50,0002025-04-15
Tommy Tuberville🏛 Senate$DUK▼ Sell$15,001 - $50,0002025-04-15
Marjorie Taylor Greene🏢 House$DUK▲ Buy$1,001 - $15,0002024-12-24
Virginia Foxx🏢 House$DUK▲ Buy$1,001 - $15,0002024-12-06
Marjorie Taylor Greene🏢 House$DUK▲ Buy$1,001 - $15,0002024-11-25
Marjorie Taylor Greene🏢 House$DUK▲ Buy$1,001 - $15,0002024-11-01
Julia Letlow🏢 House$DUK▲ Buy$1,001 - $15,0002024-10-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDUKBAX
Forward yield3.22%2.28%
Annual dividend / share$4.24$0.36
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR11.3%-27%
Portfolio after 10y$23.9K$20.6K
Annual income after 10y$1,399.71$10.26
Total dividends collected$7.6K$602.00
Payment frequencyquarterlyquarterly
SectorUtilitiesHealthcare
Analyst consensusHoldHold
Analyst price target$133.40$19.75

Year-by-year: DUK vs BAX ($10,000, DRIP)

YearDUK PortfolioDUK Income/yrBAX PortfolioBAX Income/yrGap
1$10,778$358.21$10,866$166.33$88.00BAX
2$11,643$412.40$11,750$123.31$107.00BAX
3$12,608$475.85$12,664$90.97$56.00BAX
4← crossover$13,688$550.40$13,617$66.89+$71.00DUK
5$14,901$638.26$14,619$49.07+$282.00DUK
6$16,269$742.17$15,679$35.94+$590.00DUK
7$17,818$865.52$16,802$26.30+$1.0KDUK
8$19,579$1,012.51$17,998$19.23+$1.6KDUK
9$21,590$1,188.37$19,272$14.05+$2.3KDUK
10$23,896$1,399.71$20,631$10.26+$3.3KDUK

DUK vs BAX: Complete Analysis 2026

DUKUtilities

Duke Energy Corporation, together with its subsidiaries, operates as an energy company in the United States. It operates through three segments: Electric Utilities and Infrastructure, Gas Utilities and Infrastructure, and Commercial Renewables. The Electric Utilities and Infrastructure segment generates, transmits, distributes, and sells electricity in the Carolinas, Florida, and the Midwest; and uses coal, hydroelectric, natural gas, oil, renewable generation, and nuclear fuel to generate electricity. It also engages in the wholesale of electricity to municipalities, electric cooperative utilities, and load-serving entities. This segment serves approximately 8.2 million customers in 6 states in the Southeast and Midwest regions of the United States covering a service territory of approximately 91,000 square miles; and owns approximately 50,259 megawatts (MW) of generation capacity. The Gas Utilities and Infrastructure segment distributes natural gas to residential, commercial, industrial, and power generation natural gas customers; and owns, operates, and invests in pipeline transmission and natural gas storage facilities. It has approximately 1.6 million customers, including 1.1 million customers in North Carolina, South Carolina, and Tennessee, as well as 550,000 customers in southwestern Ohio and northern Kentucky. The Commercial Renewables segment acquires, owns, develops, builds, and operates wind and solar renewable generation projects, including nonregulated renewable energy and energy storage services to utilities, electric cooperatives, municipalities, and corporate customers. It has 23 wind, 178 solar, and 2 battery storage facilities, as well as 71 fuel cell locations with a capacity of 3,554 MW across 22 states. The company was formerly known as Duke Energy Holding Corp. and changed its name to Duke Energy Corporation in April 2005. The company was founded in 1904 and is headquartered in Charlotte, North Carolina.

Full DUK Calculator →

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →
📬

Get this DUK vs BAX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DUK vs SODUK vs NEEDUK vs DDUK vs AEPDUK vs EXCDUK vs SCHDDUK vs JEPIDUK vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.